JSPR · Jasper Therapeutics, Inc.
$0.62
+0.02 (+2.72%)
At close · Jul 30
Going-concern doubt
— flagged May 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Accordingly, the Company has concluded that substantial doubt exists about its ability to continue as a going concern.”View the 10-Q filed May 14, 2026
Market Cap
$16.80M
Shares
28.00M
Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.
| Filed | Seller | Relationship | Shares | Approx. Sale | Broker |
|---|---|---|---|---|---|
| 2024-12-12 | Jeetinder Singh Mahal | Executive Officer | 900 | 2024-12-12 | Raymond James & Associates, Inc. |
| 2024-09-12 | Jeetinder Singh Mahal | Executive Officer | 900 | 2024-09-12 | Raymond James & Associates, Inc. |
| 2024-06-12 | Jeetinder Singh Mahal | Executive Officer | 900 | 2024-06-12 | Raymond James & Associates, Inc. |
| 2024-03-12 | Jeetinder Singh Mahal | Executive Officer | 900 | 2024-03-12 | Raymond James & Associates, Inc. |
| 2024-03-06 | Lis William | Director | 16,000 | 2024-03-06 | Morgan Stanley Smith Barney LLC Executive Services |
| 2023-10-13 | William Lis | Director | 7,965 | 2023-10-13 | Raymond James & Associates, Inc. |
| 2023-06-13 | Jeetinder Singh Mahal | Executive Officer | 9,000 | 2023-06-13 | Raymond James & Associates, Inc. |
| 2023-04-14 | French Anna Louise | Director | 7,000 | 2023-04-14 | ETRADE FINANCIAL CORPORATION |
| 2023-04-13 | Lis William | Director | 8,500 | 2023-04-13 | ETRADE FINANCIAL CORPORATION |
| 2023-04-13 | EMSTER KURT VON | Officer | 9,075 | 2023-04-13 | ETRADE FINANCIAL CORPORATION |
Showing 1–10 of 10 filings